Actively Recruiting
Stepped Care Treatment for Anxiety Resilience
Led by Andrew Wiese · Updated on 2026-03-02
106
Participants Needed
1
Research Sites
120 weeks
Total Duration
On this page
Sponsors
A
Andrew Wiese
Lead Sponsor
B
Baylor College of Medicine
Collaborating Sponsor
AI-Summary
What this Trial Is About
Childhood anxiety disorders (CAD) are common and impairing. Family based cognitive behavioral therapy (CBT) is efficacious in treating CAD. Yet, many children do not receive care due to barriers such as limited provider availably, high treatment costs, and constrained family resources (e.g., time). To combat these barriers, other treatment methods have been developed. The stepped care treatment models maximize resources by providing low-intensity, low-cost interventions as a first time treatment, while stepping up care for those needing more intensive treatment. Specifically, a stepped care model for CAD that begins with a parent-focus intervention has great promise to deliver efficacious and cost-effective treatment without having to engage the child. While stepped care approaches show promise in treating CAD with comparable efficacy to standard CBT, there remains a large research-to-practice gap. The stepped care model for CAD that begins with a parent-focused intervention has yet been explored, and very little is known about intervention mediators that explain mechanisms of change. This research is being done to improve the reach and quality of services using a stepped care model, offering an affordable and practical solution to the widespread gap in youth mental health care.
CONDITIONS
Official Title
Stepped Care Treatment for Anxiety Resilience
Who Can Participate
Eligibility Criteria
You may qualify if you...
- A primary diagnosis of OCD or an anxiety disorder including separation anxiety disorder, social phobia, generalized anxiety disorder, specific phobia, agoraphobia, or panic disorder confirmed by diagnostic interview
- A score of 14 or higher on the Pediatric Anxiety Rating Scale indicating clinically significant anxiety
- Child is between 7 and 17 years old
- Residence in Texas and located in Texas for treatment sessions
You will not qualify if you...
- Psychosis, cognitive disability, or any condition limiting the caregiver's ability to follow instructions
- Parent has had substance use disorder within the past 3 months that could affect treatment implementation
- Child or parent is currently suicidal; delayed entry allowed if stable for over 6 months
- Recent start or changes in psychiatric medications within 6 to 12 weeks before enrollment; medications must remain stable during treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Baylor College of Medicine
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
A
Andrew D Wiese, PhD
CONTACT
J
Jazzmine Ward, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here